PTC Therapeutics PTCT Increase (Decrease) in Deposit Assets
Increase (Decrease) in Deposit Assets at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDepositOtherAssets.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's increase (decrease) in deposit assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's increase (decrease) in deposit assets?
- PTC Therapeutics (PTCT) reported increase (decrease) in deposit assets of $1.59M in Q1 2026.
- How has PTC Therapeutics's increase (decrease) in deposit assets changed year-over-year?
- PTC Therapeutics's increase (decrease) in deposit assets increased by 159.9% year-over-year, from $611K to $1.59M.
- What does increase (decrease) in deposit assets mean?
- Tracks changes in restricted cash or collateral deposits held to secure contractual obligations, such as facility leases or service agreements. A significant change often indicates shifts in operational requirements or changes in the company's credit support arrangements.